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dure intended to prevent AAA rupture that has recently
been approved by the US Food and Drug Administration
(FDA). Although AAA rupture has not been reported in
the United States with the use of this device, there is a sig-
nificant incidence of endograft limb stenosis or occlusion
(endograft limb dysfunction [ELD]). Interventions for
stenosis and for occlusion were required in approximately
10.3% and 6.7%, respectively, of patients in the
Guidant/Endovascular Technologies FDA clinical trials.2
This report describes our clinical experience with ELD
and retrospectively analyzes a color duplex ultrasound
scanning (CDU) endograft surveillance program designed
to identify and treat limb stenoses before occlusion.
MATERIALS AND METHODS
The records of 67 patients with Endovascular
Technologies-EGS or Guidant-ANCURE endografts (58
bifurcated, 9 uniiliac) implanted between February 1996
and July 2000 were reviewed. Patients treated with aortic
The two primary goals of abdominal aortic aneurysm
(AAA) repair are prevention of aneurysm rupture and
maintenance of lower-extremity perfusion. Standard open
repair of AAA effectively prevents rupture, and lower-
extremity perfusion is usually preserved, because the inci-
dence of graft limb thrombosis is about 2%.1 The
Guidant/ANCURE aortic endograft is a treatment proce-
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Objective: The purpose of this study was to define the incidence and treatment of endograft limb stenosis or occlusion
(endograft limb dysfunction [ELD]) in a single center with the ANCURE unsupported bifurcated or aortouniiliac
endograft by using intraoperative completion angiography and postoperative color duplex ultrasound scanning (CDU).
Methods: Sixty-seven endografts (58 bifurcated, 9 uniiliac) were implanted between February 1996 and July 2000.
Intraoperative completion aortography was performed in every patient. Postoperative assessment of the endograft con-
sisted of CDU and computed tomography scanning and kidney, ureter and bladder radiographs within 7 days of
implantation, at 3 and 6 months after the operation, and every 6 months thereafter.
Results: At the time of endograft implantation, widely patent normal-appearing endograft limbs were revealed by means
of the initial completion angiogram in 58 of 67 patients (group 1). ELD subsequently developed in seven of these 58
patients (13.4%). The results of the completion angiogram were not normal in the remaining nine patients (group 2),
leading to the deployment of a self-expanding stent within the endograft limbs. The results of subsequent angiography
were normal. No ELD has occurred in any patient in group 2 to date. The primary assisted patency rate at 30 months
was 88% ± 5.2% for group 1 versus 100% ± 0% for group 2 (P = not significant, Log-rank test). Postoperative ELD
occurred in seven patients (10.4%). Endovascular graft thrombosis occurred in three patients (3 endograft limbs). In
each case, an endovascular approach was attempted; however, the guidewire would not traverse the occluded endovas-
cular graft limb. Revascularization was accomplished by means of femorofemoral bypass grafting. Endovascular graft
stenosis occurred in four patients (4 endograft limbs). Three patients with bifurcated endografts and limb stenosis who
had no symptoms diagnosed by means of CDU were successfully treated by means of balloon angioplasty with self-
expanding stent implantation, and the endograft limbs remained patent at 3, 5, and 26 months follow-up. The remain-
ing patient who had an aortouniiliac endograft with recurrent severe stenoses underwent endograft explantation and
aortobifemoral bypass grafting. The overall incidence of ELD during or after endovascular abdominal aortic aneurysm
repair was 23.8% (16 of 67 patients). 
Conclusion: Unsupported endografts are at risk for developing ELD. The use of stents for limb support at the time of
the initial endograft implantation may prevent subsequent ELD and bears further study. Endograft limb occlusion usu-
ally presents with acute severe ischemic symptoms, and the failure of operative thrombectomy necessitates femoro-
femoral artery bypass grafting. Endograft limb stenosis is identified by means of CDU surveillance in the postoperative
period. Prompt treatment with percutaneous transluminal angioplasty/stent yields satisfactory primary assisted
patency. Intraoperative intravenous ultrasound scanning, oblique angiograms, pressure gradients, and completion
angiography may be necessary to detect and treat ELD. (J Vasc Surg 2002;35:686-90.)
tube endografts were excluded from analysis, because limb
dysfunction was not an issue in this group. A total of 125
endograft limbs were at risk. Preoperative evaluation con-
sisted of aortography and 3-mm computerized tomogra-
phy (CT) scans of the abdomen and pelvis. We adhered to
the established guidelines3 of anatomic considerations for
the selection of patients (Table I). Patients enrolled in
FDA phase II or III clinical trials underwent an informed
consent process approved by the Institutional Review
Board. All procedures were performed in a standard oper-
ating room by two vascular surgeons. During endograft
deployment, each limb was fully expanded by inflating a 4-
cm-long non-compliant angioplasty balloon of a diameter
appropriate for the limb size to 6 to 8 atm. Intraoperative
diagnostic and completion aortography was performed in
all patients with the OEC 9600/9800 C-arm fluoroscope.
Postoperative endograft assessment consisted of a CDU
surveillance protocol4 and CT scans within 7 days of
implantation, at 3 and 6 months after surgery, and every 6
months thereafter. An endovascular graft occlusion was
suspected by the patient’s symptoms and confirmed with
CDU. The diagnostic threshold of a hemodynamically sig-
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nificant endovascular graft stenosis was defined by means
of the criteria in Table II. Follow-up angiography was
obtained only in conjunction with an interventional pro-
cedure. Seven patients with a diagnosis of ELD were iden-
tified (Table III).
RESULTS
The overall incidence of ELD, during either the intra-
operative or postoperative period, was 23.8% (16 of 67
patients). The mean follow-up period was 15.90 ± 4.03
months.
In this series, no routine stent implantation for the pur-
poses of limb support was performed. At the time of endo-
graft implantation, patent and normal-appearing endograft
limbs were revealed in 58 of 67 patients (group 1) by
means of the initial completion angiogram. Endograft
stenosis or occlusion subsequently developed in seven of
these 58 patients. The results of the initial completion
angiogram was not normal in 9 of 67 patients (group 2).
An endograft limb stenosis was identified in seven patients,
and a type I limb endoleak was identified in two patients.
These findings prompted immediate deployment of a self-
Table I. Endograft anatomic guidelines for patient selection
Anatomic parameter Dimensions
Superior neck ≤26 mm in diameter or ≥15 mm in length
Ipsilateral limb not < 23.5F or 7.9 mm in diameter
Contralateral limb not < 12F or 4.0 mm in diameter 
Iliac artery implantation site >20 mm in length and ≤13.4 mm in diameter
Table II. Color duplex ultrasound scanning criteria for diagnosis of graft stenosis
No significant stenosis Increase of PSV <100%, no turbulence
Significant stenosis Increase of PSV >100%, post-stenotic turbulence
Occlusion Absence of Doppler scanning signals within graft limb
PSV, Peak systolic velocity.
Table III. Patients with endograft limb dysfunction
Patient Graft configuration Signs and symptoms Stenosis/occlusion Intervention
RH Bifurcated Right LE pain, absence of Right iliac limb occlusion Femorofemoral bypass grafting
26  15 femoral pulse, POD 1
FB Bifurcated Right LE pain Right iliac limb occlusion Femorofemoral bypass grafting
24  15
HG Aortoiliac Bilateral LE pain Left iliac limb stenosis PTA, stent open bifurcated graft
left, 26  25
BT Bifurcated CDU, decreased pulse Left iliac limb occlusion Femorofemoral bypass grafting
22  14 left femoral artery
GV Bifurcated CDU Left iliac limb stenosis PTA, stent
24  15
SB Bifurcated CDU Right iliac limb stenosis PTA, stent
24  17
WD Bifurcated CDU Left iliac limb stenosis PTA, stent
24  14
LE, Lower extremity; POD, postoperative day; CDU, color duplex ultrasound scanning; PTA, percutaneous transluminal angioplasty.
expanding WALLSTENT (5 unilateral, 4 bilateral) within
the endograft limb. After this supplemental intervention,
the results of the subsequent final angiogram were normal.
No endograft stenosis or occlusion has occurred in group
2 to date. The primary assisted patency rates at 30 months
(Fig 1) were 88.0% ± 5.2% for group 1 and 100% ± 0% for
group 2 (P = not significant, Log-rank test).
The mean interval from graft implantations to the
development of ischemic symptoms or detection of a
hemodynamically significant stenosis was 6.0 ± 3.1
months. Endovascular graft occlusion with symptoms of
acute lower-extremity ischemia occurred in three patients
(4.4%), or 3 of 125 endograft limbs at risk (2.4%). One
occlusion occurred early in the postoperative period when
there was no opportunity to obtain CDU studies, another
occurred despite the normal results of a CDU study of the
endograft 2 months earlier, and the third occurred while
the patient was awaiting an endovascular intervention for
a known endograft limb stenosis. Limb occlusion was
diagnosed by means of CDU in two patients and by means
of angiography in the third patient. In each case, an
endovascular approach was attempted, but the guidewire
would not traverse the occluded endovascular graft limb.
Operative thrombectomy also proved unsuccessful,
despite multiple attempts to advance a balloon catheter or
guidewire through the occluded limb. Revascularization
was accomplished by means of femorofemoral bypass
grafting in all three patients.
CDU evidence of a hemodynamically significant
endovascular graft stenosis was found in four patients
(6.0%), or 4 of 125 endograft limbs that were at risk (3.2%).
Three patients with bifurcated endograft limb stenosis had
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no symptoms, and the stenosis was diagnosed by means of
CDU (Fig 2). The stenoses were successfully treated by
means of balloon angioplasty with self-expanding stent
implantation, and the endograft limbs remained patent at 3,
5, and 26 months’ follow-up (Fig 3). The remaining patient
with an aortouniiliac endograft had transient acute unilat-
eral leg paresis 2 years after surgery, and a significant endo-
graft limb stenosis was identified by means of CDU (Fig 4).
Balloon angioplasty of a severely kinked graft (Fig 5) with
self-expanding stent implantation was performed success-
fully on two separate occasions; however, persistent symp-
toms and CDU evidence of recurrent stenosis led to
endograft explantation and aortobifemoral bypass grafting.
DISCUSSION
The ANCURE aortic endograft is an unsupported
crimped woven Dacron prosthesis. Although similar to a
conventional aortic graft used for standard open repair, it
is not implanted into a similar environment. Standard aor-
Fig 1. Life table of primary assisted patency rate of endografts.
Group 1 represents patients with “normal” results of an initial
completion angiogram and no adjuvant use of stents for limb sup-
port. Group 2 represents patients who had abnormal results of an
initial completion angiogram and adjuvant stent implantation for
limb support (P = not significant, log-rank test).
Fig 2. Endograft limb stenosis. A, Color transverse CDU show-
ing right limb stenosis. B, Spectral analysis of a distal endograft
limb stenosis demonstrating peak systolic velocity of 440 cm/s.
A
B
tic grafts placed in the retroperitoneum are rarely com-
pressed by adjacent structures and usually do not develop
stenosis or occlusion. Furthermore, these grafts are usually
stretched to the desired length with care to avoid twists or
kinks. Alternatively, aortic endografts inserted within the
aorta and iliac arteries are subject to compression by
thrombus and plaque existing within the aneurysm and
adjacent arteries. Severe angulation may kink an endograft
limb. Unsupported endograft limbs are prone to be
implanted with twists, kinks, and pleats of fabric within the
lumen. Some degree of imperfection is tolerable and no
doubt insignificant at the time of implantation; however,
there are no data on the effect of an imperfectly implanted
endograft on blood flow or graft patency. At some time
after successful endograft repair, however, aneurysm
remodeling occurs, which results in not only diameter
reduction,5,6 but also longitudinal shrinkage.7 These con-
formational changes may distort the course of the endo-
graft, resulting in the development of either stenosis or
occlusion from impingement or kinks.
On occasion, it is apparent at some time during endo-
graft implantation that a limb requires an endoluminal
self-expanding stent to maintain patency. The presence of
plaque within the terminal aorta or iliac arteries is fre-
quently detected by the preoperative angiogram or CT
scan. The significance of plaque in this location is difficult
to determine. In a review of their experience with limb
dysfunction with the ANCURE endograft, Amesur et al8
used intravenous ultrasound scanning (IVUS) as a means
of determining whether a self-expanding stent was needed
for limb support. They eliminated postoperative ELD by
using a WALLSTENT in 46% of their patients. Although
our intervention rate was lower, the outcome was similar.
We reduced the potential for limb dysfunction in this
series by deploying a self-expanding stent for persistent
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waists seen during angioplasty balloon inflation (or defla-
tion) when used during limb expansion maneuvers, or for
findings of kinks or stenosis on the completion intraoper-
ative angiogram. Questionable lesions such as endograft
twisting, telescoping, angulation, tortuosity, or endoleaks
were further evaluated by means of oblique-view
angiograms. Pull-through arterial pressures were not used
with regularity, and IVUS studies were initiated late in this
review; therefore, no conclusions can be drawn from the
use of these tests. We now routinely use these tests in
anticipation of detecting endograft limb imperfections
that are not appreciated on a single-view completion
angiogram; this may prompt more frequent stent insertion
and, ultimately, the prevention of ELD.
The patency of endografts initially implanted with a
self-expanding stent was not statistically different from that
of endografts without any limb support. The small number
of patients with initial stent implantation probably is reflec-
Fig 3. After successful percutaneous transluminal angioplasty/
stent implantation, the results of spectral analysis are normal
(compare with Fig 2B). The other limb is not in the image plane
and is not seen.
Fig 5. Intraoperative angiogram confirming limb dysfunction
before percutaneous transluminal angioplasty and stent deployment.
Fig 4. A severe stenosis in the proximal endograft limb developed
2 years after endograft implantation. The velocity at the stenosis
was 404 cm/s, compared with 85 cm/s in an adjacent segment.
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tive of the careful patient selection performed to avoid
complications and prevent conversion to standard open
repair during the FDA clinical trials. Because no limb dys-
function occurred in endograft limbs containing a self-
expanding stent, we conclude that radial endograft support
may be beneficial in maintaining endograft limb patency. A
similar conclusion was reached by Baum9 in a review of the
occurrence of endograft limb kinking. Supplemental stent
implantation for limb kinks was required in 8 of 12 patients
who received an unsupported endograft, compared with 5
of 74 patients with a supported endograft. However, it is
evident from our review that most patients with an unsup-
ported endograft do not require limb support.
In this study review of ELD, endograft limb occlusion
presented with acute severe lower-extremity ischemia.
Attempts at operative thrombectomy in our experience
were not successful. We experienced difficulty traversing
the affected limb with thrombectomy catheters or
hydrophilic guidewires and believe this was probably
because of lumen obstruction by folds of fabric from the
collapsed graft wall. We have not had an opportunity to
use thrombolysis and stenting, as reported by other
authors.8 Our experience with ELD is similar to that in
other studies, which indicated that endograft limb occlu-
sion frequently necessitates femorofemoral bypass grafting
or graft explantation.10-12
Postoperative CDU evidence of hemodynamically sig-
nificant endograft limb stenosis occurred in 6% of the
patients in this report. CDU is an effective tool for the
assessment of lower-extremity bypass grafts13 and aortic
endografts.14 During our participation in the aortic
aneurysm endograft clinical trials, we routinely used peri-
odic postoperative CDU surveillance of the aneurysm sac,
the endograft, and adjacent arteries. We have previously
reported on the value of CDU in detecting endoleaks and
have described our technical protocol in detail.4 Wolf15
recently found CDU to be comparable with CT angiogra-
phy for the assessment of aneurysm size, endoleak, and
graft patency. Early in our experience of CDU surveillance
of endografts, when limb stenosis was detected, an inter-
vention was scheduled as soon as possible. An unavoidable
10-day delay in the treatment of an endograft stenosis in
one case resulted in the progression to acute limb occlu-
sion. In all other cases, there was prompt treatment from
the time of diagnosis of limb dysfunction, which resulted in
continued limb patency. We now prefer to avoid having to
treat limb occlusion by using frequent CDU surveillance,
and we urgently treat any limb stenosis that is identified.
CONCLUSION
Unsupported endografts are at risk for developing
ELD, despite normal results on a completion angiogram,
which suggests that additional diagnostic tests, such as
IVUS, oblique angiograms, and pull-through pressure
measurements, may be important in ensuring patency.
Endograft limb occlusion usually presents with acute severe
ischemic symptoms, and the failure of operative thrombec-
tomy necessitates femorofemoral artery bypass grafting.
Unlike standard open repair of AAA, in which aortic graft
patency is generally considered to be excellent and surveil-
lance is not used with regularity, an unsupported aneurysm
endograft requires periodic postoperative assessment.
CDU surveillance is an effective means of identifying ELD
in endografts. With the detection of any flow-limiting
stenosis and subsequent stent implantation, the morbidity
of graft thrombosis may be prevented. The use of adjuvant
limb support at the time of initial endograft implantation
may prevent subsequent limb dysfunction and bears fur-
ther study. The value of the routine use of limb support in
unsupported endografts remains to be determined.
We thank Courtney Nelms, BS, RVT, RDMS, Felicia
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